Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compounds as immunomodulators

Heterocyclic compounds as immunomodulators

US Patent 11465981 · Granted Oct 11, 2022

Estimated economic value: $48,346,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Carboxamide compounds and uses thereof2025
Heterocyclic compounds as immunomodulators2025
Heterocyclic compounds as immunomodulators2025
Bicyclic amines as CDK2 inhibitors2025
Bicyclic amines as CDK2 inhibitors2025
Weakly-supervised object detection using one or more neural networks2025
Tricyclic compounds as inhibitors of KRAS2025
Pyrazolopyrimidine compounds and uses thereof2025
Pyrazolopyrimidine compounds and uses thereof2025
Naphthyridine compounds as inhibitors of KRAS2025
Tricyclic heterocycles as FGFR inhibitors2025
Adenosine receptor antagonist2025